Showing results (141-150 of 201) with videos related to
Sort By:
Pageof 21
Cancer Genetics and Cytogenetics|December 1, 1992
Fluorescence in situ hybridization to determine engraftment status after murine bone marrow transplantA L Hawkins, R J Jones, B A Zehnbauer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantationA Bedi, C B Miller, J L Hanson, et al.Radiology|June 1, 1997
Hodgkin and non-Hodgkin lymphoma: local-regional radiation therapy after bone marrow transplantationR A Abrams, P J Liu, R F Ambinder, et al.Pharmaceutical Research|November 26, 1999
Aryl ester prodrugs of cyclic HPMPC. I: Physicochemical characterization and in vitro biological stabilityR Oliyai, J P Shaw, C M Sueoka-Lennen, et al.Journal of the National Cancer Institute|January 15, 1992
Phase I-II trial of erythropoietin in the treatment of cisplatin-associated anemiaC B Miller, L C Platanias, S R Mills, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1991
Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patientsL C Platanias, C B Miller, R Mick, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 8, 1999
A human-murine chimera model for in utero human hematopoietic stem cell transplantationW Leung, K Blakemore, R J Jones, et al.Oral Surgery, Oral Medicine, and Oral Pathology|October 1, 1991
Oral mucositis after bone marrow transplantation. A marker of treatment toxicity and predictor of hepatic veno-occlusive diseaseJ R Wingard, C S Niehaus, D E Peterson, et al.Blood|May 15, 1995
Assessment of aldehyde dehydrogenase in viable cellsR J Jones, J P Barber, M S Vala, et al.Journal of Medical Microbiology|February 1, 1986
Characterisation of mouse monoclonal antibodies produced by immunisation with a single serotype component of a polyvalent Pseudomonas aeruginosa vaccineG R Barclay, P L Yap, D B McClelland, et al.Pageof 21